Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis (ALPHA)
Antibiotic prophyLaxis Versus Placebo in Infants Diagnosed With Hydronephrosis Antenatally
Sponsor: Hamilton Health Sciences Corporation
This NA trial investigates Hydronephrosis and Urinary Tract Infection and is currently ongoing. Hamilton Health Sciences Corporation leads this study, which shows 12 recorded versions since 2010 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
12 versions recorded-
Nov 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
May 2022 — Nov 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Mar 2021 — May 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Apr 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hamilton Health Sciences Corporation
- McMaster Surgical Associates
- McMaster University
- The Physicians' Services Incorporated Foundation
For direct contact, visit the study record on ClinicalTrials.gov .